BACKGROUND The long-term prognosis of patients with variant angina presenting with aborted sudden cardiac death
outcomes (4) (5) (6) . Other studies have reported favorable long-term outcomes (7-9). This uncertainty has led to variations in treatment, with some cardiologists favoring implantable cardioverter-defibrillators (ICDs) (10) and others believing that coronary spasms are reversible and can be controlled by intensive vasodilator treatment (11) .
Therefore, to overcome mixed evidence from anecdotal reports hampered by the limited number of patients and short follow-up periods, and to provide clinically relevant information in long-term appropriate management for this high-risk subset, a large multicenter cohort study with long-term follow-up was of paramount importance. In this study, we hypothesized that patients presenting with ASCD would have worse long-term prognosis, which would be irreversible to optimal vasodilator therapy only. To test our hypothesis, we first evaluated the long-term risk of mortality and ventricular tachyarrhythmic events in patients with variant angina with ASCD compared with those without ASCD. Second, we compared cardiac mortality between patients who received ICDs or did not in ASCD patients.
METHODS
STUDY DESIGN AND PATIENTS. This is a retrospective observational cohort study that discusses the characteristics of patients with variant angina with ASCD or without ASCD from 13 major heart centers in The non-ASCD group consisted of patients who had positive coronary artery spasm provocation tests due to typical or atypical angina-like chest pain suspected of being variant angina. In general, angina at rest in the early morning or at night was the hallmark feature that prompted the provocation test. Ergonovine provocation coronary angiography or echocardiography were used as provocation tests and were performed according to standard methods, which are described in the Online Appendix (12, 14) . (20) . No relevant violations were found. Final models are provided in Online Table 1 . We also performed additional adjustments for differences in baseline patient characteristics with propensity score matching (21, 22) and weighted Cox
proportional hazards regression models with inverseprobability-of-treatment weighting (IPTW) (23, 24) . In the matched cohorts, survival curves were constructed with Kaplan-Meier estimates and compared using methods described previously (22) . Multivariate An ICD was implanted in 24 patients (12.8%). For
Prognosis of Variant Angina With ASCD non-ASCD patients, coronary spasm was documented by ergonovine provocation echocardiogram (n ¼ 1,020) and ergonovine provocation coronary angiogram (n ¼ 824). Overall, ASCD patients were younger (52.8 AE 9.9 years vs. 55.3 AE 9.5 years; p ¼ 0.001); they had more frequent multivessel spasms (17.0% vs. 9.3%; p ¼ 0.001), had a lower incidence of hypertension (34.0% vs. 49.5%; p < 0.001), hyperlipidemia (14.4% vs. 30.4%; p < 0.001), and family history of sudden cardiac death (2.7% vs. 0.9%; p ¼ 0.021), and took more vasodilators than non-ASCD patients (2.6 AE 0.9 vs. 2.3 AE 0.8; p < 0.001) ( Table 1) . Among the ASCD patients who experienced clinical events of cardiac death and ventricular tachyarrhythmia, all but 2 patients received at least 2 vasodilator therapies (Online Table 2 ). Table 2 ). In addition, propensity score matching was used to assemble a cohort of patients with similar baseline characteristics. After matching, baseline characteristics were balanced between 172 pairs (Online Table 3 ). Patients with ASCD, compared with those without ASCD, had a higher risk of cardiac death (HR: 9.81; 95% CI: 3.02 to 31.8; p < 0.001) ( Figure 1A ) and death from any cause (HR: 4.09; 95% CI: 2.28 to 10.5; p < 0.001) ( Figure 1B) .
The results after adjustment by IPTW was consistent ( Table 2) .
We also evaluated independent predictors of mortality in our cohort. These included ASCD (HR: patient-years ( Figure 2A ). Recurrent myocardial patient-years ( Figure 2B ). A total of 24 ASCD patients received ICDs and had more vasodilator treatment (Online Table 4 CI ¼ confidence interval; HR ¼ hazard ratio; IPTW ¼ inverse probability-of-treatment weight; other abbreviation as in Table 1 . In this large registry, we confirmed the favorable long-term prognosis of patients with variant angina without ASCD, and our event rates were consistent with previous studies. The 10-year survival rate in patients with variant angina has been reported to be 93% (2) . Another large Japanese registry reported a 98% survival rate after 5 years (5). Cardiac Death or Ventricular Tachyarrhythmia 
